"Since 1992, St. Charles Psychiatric Associates is a group of physicians and several psychotherapists working together in an outpatient clinic to HELP PEOPLE. We do this by careful assessment of each client in order to treat them as an individual. We understand no two people are alike. We discuss treatment, rationale for treatment and available options in order to HELP. Whether it is a medicine, talk therapy, a combination of both or a referral, we will discuss the options and our expert recommendation. We have treated mothers, fathers, sisters and brothers in the surrounding St. Louis region for over 25 years. We are a caring a compassionate group of people with the same goal: HELP PEOPLE."

During the past decade, St. Charles Psychiatric Associates - Midwest Research Group conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 36 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 21 clinical trials were completed. i.e. 161.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Charles Psychiatric Associates - Midwest Research Group" #1 sponsor was "Sunovion" with 16 trials, followed by "Shire" with 13 trials sponsored, "Forest Laboratories" with 5 trials sponsored, "Naurex, Inc, an affiliate of Allergan plc" with 4 trials sponsored and "Supernus Pharmaceuticals, Inc." with 4 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Charles Psychiatric Associates - Midwest Research Group" #1 collaborator was "H. Lundbeck A/S" with 1 trials as a collaborator, "Shire" with 1 trials as a collaborator and "Takeda" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "St. Charles Psychiatric Associates - Midwest Research Group" are "Major Depressive Disorder" (12 trials), "Schizophrenia" (10 trials), "Depressive Disorder, Major" (6 trials), "Binge Eating Disorder" (5 trials) and "Attention Deficit Hyperactivity Disorder" (4 trials). Many other conditions were trialed in "St. Charles Psychiatric Associates - Midwest Research Group" in a lesser frequency.

Most popular intervention types in "St. Charles Psychiatric Associates - Midwest Research Group" are "Drug" (65 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (36 trials), "Lurasidone" (6 trials), "Rapastinel" (4 trials), "Dasotraline" (3 trials) and "Lisdexamfetamine dimesylate" (3 trials). Other intervention names were less common.

The vast majority of trials in "St. Charles Psychiatric Associates - Midwest Research Group" are 65 trials for "All" genders.

Currently, there are NaN active trials in "St. Charles Psychiatric Associates - Midwest Research Group". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 49 completed trials in St. Charles Psychiatric Associates - Midwest Research Group, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in St. Charles Psychiatric Associates - Midwest Research Group, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 49 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 0 trials that are defined as “Not Applicable".